COMMUNIQUÉS West-GlobeNewswire

Interpace Diagnostics Expands Application of Pancreatic Cancer Test
19/07/2018
PancraGEN® Gaining Further Guideline Support and Expanded Use for Multiple New Indications PARSIPPANY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace [...]
MPX Enters Into Extraction Agreement With Southern California’s Largest Cannabis Processing Facility, Case Farms Collective
19/07/2018
Relationship will provide a full scale operation of services to MPX’s proprietary specifications and guidelines, establishing the Company’s footprint in California TORONTO, July 19, 2018 (GLOBE NEWSWIRE) -- MPX [...]
Arbutus to Report Second Quarter 2018 Financial Results
19/07/2018
WARMINSTER, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its second [...]
Mustang Bio Completes Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)
19/07/2018
IND filing for MB-102 in BPDCN, AML and high-risk myelodysplastic syndrome on track for Q4 2018 NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) [...]
Trinity Biotech Announces Results for Q2, 2018
19/07/2018
DUBLIN, Ireland, July 19, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced [...]
GTX Corp Engages Doost, Inc. to Open Retail Channels
19/07/2018
LOS ANGELES, July 19, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, today announces the [...]
Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results
19/07/2018
SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 9, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Poseida Therapeutics Appoints John P. Schmid to Board of Directors
19/07/2018
SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. , a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced the appointment [...]
Chembio Diagnostics Appoints Christine Rousseau, Ph.D. as Vice President, Corporate Development
19/07/2018
MEDFORD, N.Y., July 19, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced the appointment of Christine M. Rousseau, Ph.D. as Vice [...]
Women In Bio Announces Completion of the 2018 Boardroom Ready Selection Process
19/07/2018
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, is pleased to announce [...]
Progressive Care Signs Two New 340B Contracts to Bring Discounted Prescription Programs to Non-Profit Healthcare Institutions
19/07/2018
MIAMI, July 19, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that they have signed two new 340B contracts, furthering their [...]
PhaseBio Appoints Caroline M. Loewy to Board of Directors
19/07/2018
MALVERN, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of therapies for orphan diseases with an initial focus on [...]
Mersana Therapeutics Announces Partial Clinical Hold for XMT-1522 Clinical Trial
19/07/2018
CAMBRIDGE, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc.(NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
HempAmericana CEO Issues New Letter to Shareholders
19/07/2018
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, As we navigate the [...]
Abattis Enters Into Definitive Agreement to Sell Northern Vine Interest
19/07/2018
VANCOUVER, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement ( [...]
Tetra Natural Health Announces Upcoming Launch of Hemp Energy Drink
19/07/2018
ORLEANS, Ontario, July 19, 2018 (GLOBE NEWSWIRE) -- Tetra Natural Health Inc., a division of Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP) (OTCQB:TBPMF), announced that it will be commercializing [...]
Epizyme Announces Date of Second Quarter 2018 Financial Results and Business Update Conference Call
19/07/2018
CAMBRIDGE, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, today announced that it plans to report its second quarter 2018 financial [...]
Misonix Names Leading Medical Device Executive Gwen Watanabe to Board of Directors
19/07/2018
Current Teleflex Incorporated Executive and Accomplished Industry Entrepreneur Brings Strategic Leadership and Deep Expertise with Growing Medical Device Companies to the Misonix Board FARMINGDALE, N.Y., July 19, 2018 ( [...]
ReWalk Completes Amendment with Wyss Institute at Harvard University to Extend Agreement to June 2022
19/07/2018
Allows Company to Complete Additional Research Programs, Pace Efforts More Efficiently and Benefit Cash Flow MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 19, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: [...]

Pages